Last updated: 3 months ago
Alterity Therapeutics 2025 SEC Form 6-K: A$40M Raised for MSA Drug Development
Discover Alterity Therapeutics Limited's latest SEC Form 6-K, detailing A$40M raised for ATH434's development targeting Multiple System Atrophy (MSA).